rts logo

Hookipa Pharma Inc (HOOK) Volatility At 5.53%, Should You Add A Position?

Hookipa Pharma Inc (NASDAQ: HOOK) is -5.06% lower on its value in year-to-date trading and has touched a low of $0.41 and a high of $2.05 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HOOK stock was last observed hovering at around $0.76 in the last trading session, with the day’s gains setting it 0.01%.

Currently trading at $0.77, the stock is 4.41% and 9.43% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.9 million and changing 1.18% at the moment leaves the stock 13.27% off its SMA200. HOOK registered 4.48% gain for a year compared to 6-month gain of 28.38%. The firm has a 50-day simple moving average (SMA 50) of -$1.76 and a 200-day simple moving average (SMA200) of $0.46.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -4.94% loss in the last 1 month and extending the period to 3 months gives it a -7.35%, and is 6.95% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.53% over the week and 6.13% over the month.

Hookipa Pharma Inc (HOOK) has around 151 employees, a market worth around $76.09M and $20.13M in sales. Profit margin for the company is -405.29%. Distance from 52-week low is 87.56% and -62.49% from its 52-week high. The company has generated returns on investments over the last 12 months (-87.10%).

Hookipa Pharma Inc quarterly earnings per share for the current quarter are estimated at -$0.1 with sales reaching $2.8M over the same period.The EPS is expected to grow by 58.43% this year, but quarterly earnings will post 63.40% year-over-year. Quarterly sales are estimated to shrink -36.20% in year-over-year returns.

48 institutions hold shares in Hookipa Pharma Inc (HOOK), with institutional investors hold 48.93% of the company’s shares. The shares outstanding are 96.55M, and float is at 70.40M with Short Float at 0.47%. Institutions hold 39.34% of the Float.

The top institutional shareholder in the company is Artal Group S.A. with over 5.67 million shares valued at $4.99 million. The investor’s holdings represent 6.95% of the HOOK Shares outstanding. As of Jun 29, 2023, the second largest holder is Knoll Capital Management, LLC with 5.52 million shares valued at $4.86 million to account for 6.77% of the shares outstanding. The other top investors are FMR, LLC which holds 4.83 million shares representing 5.92% and valued at over $4.25 million, while EcoR1 Capital, LLC holds 5.63% of the shares totaling 4.6 million with a market value of $4.04 million.

Hookipa Pharma Inc (HOOK) Insider Activity

The most recent transaction is an insider purchase by Kandera Reinhard, the company’s Chief Financial Officer. SEC filings show that Kandera Reinhard bought 7,000 shares of the company’s common stock on Aug 21 ’23 at a price of $0.72 per share for a total of $5075.0. Following the purchase, the insider now owns 43092.0 shares.

Hookipa Pharma Inc disclosed in a document filed with the SEC on Aug 16 ’23 that Kandera Reinhard (Chief Financial Officer) bought a total of 8,000 shares of the company’s common stock. The trade occurred on Aug 16 ’23 and was made at $0.71 per share for $5712.0. Following the transaction, the insider now directly holds 36092.0 shares of the HOOK stock.

Still, SEC filings show that on Jul 11 ’23, Aldag Jorn (Chief Executive Officer) acquired 5,000 shares at an average price of $0.83 for $4142.0. The insider now directly holds 71,952 shares of Hookipa Pharma Inc (HOOK).

Related Posts